478.65

+1.87%↑

SANES

9.95

+1.75%↑

SAF

286.8

-0.24%↓

BBVA

19.19

+2.76%↑

BNP

84.76

+2.15%↑

478.65

+1.87%↑

SANES

9.95

+1.75%↑

SAF

286.8

-0.24%↓

BBVA

19.19

+2.76%↑

BNP

84.76

+2.15%↑

478.65

+1.87%↑

SANES

9.95

+1.75%↑

SAF

286.8

-0.24%↓

BBVA

19.19

+2.76%↑

BNP

84.76

+2.15%↑

478.65

+1.87%↑

SANES

9.95

+1.75%↑

SAF

286.8

-0.24%↓

BBVA

19.19

+2.76%↑

BNP

84.76

+2.15%↑

478.65

+1.87%↑

SANES

9.95

+1.75%↑

SAF

286.8

-0.24%↓

BBVA

19.19

+2.76%↑

BNP

84.76

+2.15%↑

Kodu・Aktsiate loetelu・Metrovacesa SA

Metrovacesa SA

Avatud

SektorRahandus

11.8 1.29

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

11.66

Max

11.86

Põhinäitajad
By Trading Economics
Sissetulek	-7.7M
Müük	66M
P/E Sektori keskmine	29.474 55.155
Kasumimarginaal	-11.69
Töötajad	214

Dividendid
By Dow Jones
Järgmine tulemuste avaldamine	30. apr 2026

Turustatistika
By TradingEconomics
Turukapital	1.7B
Eelmine avamishind	10.51
Eelmine sulgemishind	11.8

Uudiste sentiment

By Acuity

91%

8 / 440 Pingereas Finance

Tehniline skoor

By Trading Central

Kindlus

Weak Bullish Evidence

11.45 / 11.7 Toetus ja vastupanu

Metrovacesa SA Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

6. apr 2026, 23:17 UTC

Tulu

Samsung Forecasts Record First-Quarter Operating Profit

6. apr 2026, 23:00 UTC

Kuumad aktsiad

Stocks to Watch: Health Insurers, Mawson, Owlet

6. apr 2026, 22:13 UTC

Suurimad hinnamuutused turgudel

Health Insurance Shares Gain on 2.48% Medicare Rate Bump

6. apr 2026, 21:46 UTC

Omandamised, ülevõtmised, äriostud

BP 'Optimizes Portfolio' and Sells 13 Thorntons Stores to Giant Oil -- OPIS

6. apr 2026, 17:09 UTC

Suurimad hinnamuutused turgudel

Viridian Shares Fall After Competing Amgen Eye Drug Performs Well

6. apr 2026, 16:56 UTC

Uudisväärsed sündmused

U.S. Released 1.5 Million Bbls of Crude From SPR Last Week, DOE Data Show -- OPIS

6. apr 2026, 14:47 UTC

Suurimad hinnamuutused turgudel

Stereotaxis Shares Rise on FDA Clearance for Synchrony

7. apr 2026, 00:00 UTC

Uudisväärsed sündmused

Ukraine's Lesson for Trump: Military Dominance Opens Waterways -- WSJ

6. apr 2026, 23:58 UTC

Market Talk

Uudisväärsed sündmused

Iran War Will Keep Oil Prices High Through 2Q, Says Westpac -- Market Talk

6. apr 2026, 23:50 UTC

Market Talk

Nikkei May Rise on Hopes for Iran Cease-Fire -- Market Talk

6. apr 2026, 23:36 UTC

Market Talk

Gold Edges Higher as Investors Focus on U.S.-Iran Conflict -- Market Talk

6. apr 2026, 23:15 UTC

Market Talk

RBA Won't Raise Rates as Australia's Economy Softens Fast -- Market Talk

6. apr 2026, 22:52 UTC

Market Talk

Global Equities Roundup: Market Talk

6. apr 2026, 22:52 UTC

Market Talk

Pro Medicus Unlikely to Complete New Buyback in Full -- Market Talk

6. apr 2026, 22:14 UTC

Market Talk

Correction to Live Cattle Futures Article

6. apr 2026, 20:56 UTC

Market Talk

Mexican Private Consumption Fell in January -- Market Talk

6. apr 2026, 20:50 UTC

Market Talk

Energy & Utilities Roundup: Market Talk

6. apr 2026, 20:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

6. apr 2026, 19:58 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

6. apr 2026, 19:58 UTC

Market Talk

Live Cattle Futures Hit Record High, Hogs Edge Up -- Market Talk

6. apr 2026, 19:11 UTC

Market Talk

U.S. Natural Gas Edges Up in Rangebound Trade -- Market Talk

6. apr 2026, 19:06 UTC

Market Talk

Treasury Yields Decline as a Belligerent Trump Talks to Reporters -- Market Talk

6. apr 2026, 19:03 UTC

Market Talk

Global Energy Roundup: Market Talk

6. apr 2026, 19:03 UTC

Market Talk

Crude Futures Edge Up As Trump's Iran Deadline Nears -- Market Talk

6. apr 2026, 18:36 UTC

Omandamised, ülevõtmised, äriostud

Soleno Stock Soars 32% on $2.9 Billion Neurocrine Buyout. Why Its Hunger Drug Is a Different Weight-Loss Play. -- Barrons.com

6. apr 2026, 17:59 UTC

Market Talk

Uudisväärsed sündmused

Travel Booking Companies Facing More Demand Uncertainty Than Expected -- Market Talk

6. apr 2026, 17:13 UTC

Omandamised, ülevõtmised, äriostud

Soleno Stock Soars 32% on $2.9 Billion Neurocrine Buyout. Why Its Hunger Drug Is a Different Weight-Loss Play. -- Barrons.com

6. apr 2026, 16:33 UTC

Market Talk

Oil Futures Steady as Market Awaits Trump -- Market Talk

6. apr 2026, 16:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

6. apr 2026, 14:59 UTC

Tulu

Strategy Records a $14.5 Billion Unrealized Loss in First Quarter -- WSJ

Võrdlus sarnastega

Hinnamuutus

Metrovacesa SA Prognoos

Hinnangu Konsensus

By TipRanks

0 ratings

Osta

Hoia

Müü

Põhineb 0 analüütiku instrumendi Metrovacesa SA aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

11.45 / 11.7Toetus ja vastupanu

Bullish events outweigh bearish events.

All events are bullish.

Sentiment

By Acuity

8 / 440 Pingereas Rahandus

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest Metrovacesa SA

Metrovacesa S.A. operates as a real estate development company in Spain. The company develops and sells residential and commercial premises, as well as sells land. Metrovacesa S.A. was founded in 1918 and is based in Madrid, Spain.

Muud aktsiad sektorist

LVMH Moet Hennessy Louis Vuitton SE.

478.65

↑ +1.87%

SANES

Banco Santander SA

9.95

↑ +1.75%

SAF

Safran SA.

286.8

↓-0.24%

BBVA

Banco Bilbao Vizcaya Argentaria SA

19.19

↑ +2.76%

BNP

BNP Paribas SA

84.76

↑ +2.15%

Metrovacesa SA

Ülevaade

Aktsiahinna muutus

Põhinäitajad

Dividendid

Turustatistika

Uudiste sentiment

Tehniline skoor

Metrovacesa SA Graafik

Seotud uudised

Võrdlus sarnastega

Metrovacesa SA Prognoos

Hinnangu Konsensus

Tehniline skoor

Sentiment

Finantsandmed

Ettevõttest Metrovacesa SA

Muud aktsiad sektorist